Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy Young

Showing results (91-100 of 105) with videos related to

Pageof 11
Sort By:
Plos Genetics|April 5, 2014
A LINE-1 insertion in DLX6 is responsible for cleft palate and mandibular abnormalities in a canine model of Pierre Robin sequenceZena T Wolf, Elizabeth J Leslie, Boaz Arzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast CancerUzma S Asghar, Alexis R Barr, Ros Cutts, et al.
Lancet Regional Health. Americas|October 17, 2022
Adoption of digital tools in the context of the COVID-19 pandemic in the Region of the Americas - the Go.Data experienceCristina Valencia, Giovanna Jaramillo-Gutierrez, Analía Rearte, et al.
Cell Chemical Biology|May 20, 2026
Giredestrant immobilizes the estrogen receptor to exert potent antitumor efficacy against ER-active breast cancersWei Zhou, Musaddeque Ahmed, Jane Guan, et al.
Molecular Cancer Therapeutics|March 5, 2016
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma ModelsElizabeth A Punnoose, Joel D Leverson, Franklin Peale, et al.
Nature Communications|April 20, 2022
Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitorsKristin M Zimmerman Savill, Brian B Lee, Jason Oeh, et al.
Cell|February 21, 2017
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in CancerMichael R Burgess, Eugene Hwang, Rana Mroue, et al.
Journal of the American Society of Nephrology : JASN|April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session DurationLaura M Dember, Eduardo Lacson, Steven M Brunelli, et al.
Journal of Medicinal Chemistry|January 18, 2014
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitorsSteven T Staben, Jianwen A Feng, Karen Lyle, et al.
Cell|July 30, 2019
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its MobilityJane Guan, Wei Zhou, Marc Hafner, et al.
Pageof 11

Showing results (91-100 of 105) with videos related to

Sort By:
Pageof 11
Plos Genetics|April 5, 2014
A LINE-1 insertion in DLX6 is responsible for cleft palate and mandibular abnormalities in a canine model of Pierre Robin sequenceZena T Wolf, Elizabeth J Leslie, Boaz Arzi, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 14, 2017
Single-Cell Dynamics Determines Response to CDK4/6 Inhibition in Triple-Negative Breast CancerUzma S Asghar, Alexis R Barr, Ros Cutts, et al.
Lancet Regional Health. Americas|October 17, 2022
Adoption of digital tools in the context of the COVID-19 pandemic in the Region of the Americas - the Go.Data experienceCristina Valencia, Giovanna Jaramillo-Gutierrez, Analía Rearte, et al.
Cell Chemical Biology|May 20, 2026
Giredestrant immobilizes the estrogen receptor to exert potent antitumor efficacy against ER-active breast cancersWei Zhou, Musaddeque Ahmed, Jane Guan, et al.
Molecular Cancer Therapeutics|March 5, 2016
Expression Profile of BCL-2, BCL-XL, and MCL-1 Predicts Pharmacological Response to the BCL-2 Selective Antagonist Venetoclax in Multiple Myeloma ModelsElizabeth A Punnoose, Joel D Leverson, Franklin Peale, et al.
Nature Communications|April 20, 2022
Distinct resistance mechanisms arise to allosteric vs. ATP-competitive AKT inhibitorsKristin M Zimmerman Savill, Brian B Lee, Jason Oeh, et al.
Cell|February 21, 2017
KRAS Allelic Imbalance Enhances Fitness and Modulates MAP Kinase Dependence in CancerMichael R Burgess, Eugene Hwang, Rana Mroue, et al.
Journal of the American Society of Nephrology : JASN|April 20, 2019
The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session DurationLaura M Dember, Eduardo Lacson, Steven M Brunelli, et al.
Journal of Medicinal Chemistry|January 18, 2014
Back pocket flexibility provides group II p21-activated kinase (PAK) selectivity for type I 1/2 kinase inhibitorsSteven T Staben, Jianwen A Feng, Karen Lyle, et al.
Cell|July 30, 2019
Therapeutic Ligands Antagonize Estrogen Receptor Function by Impairing Its MobilityJane Guan, Wei Zhou, Marc Hafner, et al.
Pageof 11